WLR-774

GPTKB entity

Properties (11)
Predicate Object
gptkbp:instanceOf chemical compound
gptkbp:chemicalFormula C20H22N4O3S
gptkbp:developedBy Wolverine_Therapeutics
gptkbp:firstClaim oncology
gptkbp:future_plans clinical trials
https://www.w3.org/2000/01/rdf-schema#label WLR-774
gptkbp:isATypeOf 123456-78-9
gptkbp:targets cancer cells
gptkbp:triggerType inhibits specific enzymes
gptkbp:type small molecule
gptkbp:weight 398.48 g/mol